CD4 and neoplasm: Given the evidence that Foxp3+CD4+ T cells gain an edge in accessing the tumor microenvironment through a combination of differential chemokine receptor expression and an increased capacity to migrate in response to hypoxia-induced chemokines and VEGF-A, it is reasonable to speculate that migration does contribute to their observed enrichment within the tumor microenvironment.